tiprankstipranks
RBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
PremiumThe FlyRBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
3M ago
4D Molecular falls after wet AMD data is viewed as mixed
Premium
The Fly
4D Molecular falls after wet AMD data is viewed as mixed
3M ago
4D Molecular price target raised to $39 from $38 at Chardan
Premium
The Fly
4D Molecular price target raised to $39 from $38 at Chardan
3M ago
4D Molecular Therapeutics to Present PRISM Trial Interim Data
PremiumCompany Announcements4D Molecular Therapeutics to Present PRISM Trial Interim Data
5M ago
Chardan maintains odds of success assumptions for 4D Molecular after data
Premium
The Fly
Chardan maintains odds of success assumptions for 4D Molecular after data
5M ago
RBC thinks 4D-150 continues to look ‘best-in-class’ despite ‘safety blip’
Premium
The Fly
RBC thinks 4D-150 continues to look ‘best-in-class’ despite ‘safety blip’
5M ago
4D Molecular presents interim data from Phase 1/2 AEROW trial
PremiumThe Fly4D Molecular presents interim data from Phase 1/2 AEROW trial
6M ago
4D Molecular reports Q1 EPS (66c), consensus (74c)
Premium
The Fly
4D Molecular reports Q1 EPS (66c), consensus (74c)
7M ago
4D Molecular price target raised to $40 from $35 at RBC Capital
Premium
The Fly
4D Molecular price target raised to $40 from $35 at RBC Capital
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100